Building the mitochondrial genome editing repertoire

构建线粒体基因组编辑库

基本信息

  • 批准号:
    9767023
  • 负责人:
  • 金额:
    $ 39.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-21 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

Abstract Mitochondria have critical normal roles in metabolism, organ homeostasis, apoptosis and aging. Mitochondria play important but still largely mysterious roles in human physiology. Mutations in both nuclear DNA associated with proteins imported into mitochondria as well as mitochondrial DNA (mtDNA) are pathogenic. Despite this clear association of genotype with disease, there are no current treatments for patients with mitochondrial disease. Mitochondria represent a unique cellular compartment with different DNA and RNA repair and editing rules. For example, DNA nucleases that introduce double strand breaks and subsequent repair in nuclear DNA induce the degradation of mtDNA. Indeed, none of the common repair pathways found in the nucleus are active in mitochondria. This proposal uses the well-established TALE-based programmable DNA binding system for targeting mtDNA and the single-tube FUSX TALE assembly system to rapidly generate any protein-based genome engineering reagents. Similarly, we use a new, protein-based and programmable RNA binding system based on PPR proteins, a class of naturally occurring, mitochondrially localized RNA editors from plants. This application harnesses the unique environment of mitochondria to generate a new toolbox to expand the repertoire of tools to edit the human genome (RFA-RM-18-017). To develop these new molecular reagents for mtDNA and mtRNA editing of somatic cells, we will conduct the following aims: I. Develop new classes of mtDNA editing tools. Enhanced approaches to the use of mitoTALENs for preferential degradation of pathogenic mtDNA variants for MELAS and KSS will be developed, including novel nuclearly encoded reporters to detect non-mitochondrial off-targeting gene editing events. A new class of TALE mitochondrial base editors will be developed to directly edit mtDNA for pathogenic variants. II. mtRNA editing tools will be generated through harnessing the PPR family of naturally occurring programmable RNA editors. We will use our new FUSR assembly system to rapidly develop optimal RNA binding reagents, including the fusion to a set of test RNA nuclease or editing protein domains. Errant fusion transcripts in mtDNA deletion or single base variants in heteroplasmic cells will be used as the test paradigm for potential RNA editing platform development with the potential use as a therapeutic. Milestones for initial stages include the establishment of novel mtDNA heteroplasmy converting mitoTALENs against MELAS and KSS followed by testing of the new mtDNA base editor. For mtRNA editing, establishing PPR scaffolding rules for mtRNA binding followed by new programmable RNA nucleases and editors will be established. Deliverables include these novel mtDNA and mtRNA editing systems as well as humans cells with matched nuclearly encoded off-target reporter cassettes for use by any mitochondrial gene editing therapeutic system.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KARL J CLARK其他文献

KARL J CLARK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KARL J CLARK', 18)}}的其他基金

Development of tools for site-directed analysis of gene function
基因功能定点分析工具的开发
  • 批准号:
    10187374
  • 财政年份:
    2020
  • 资助金额:
    $ 39.75万
  • 项目类别:
Development and genetics of rapid neuroendocrine stress response
快速神经内分泌应激反应的发育和遗传学
  • 批准号:
    9796476
  • 财政年份:
    2019
  • 资助金额:
    $ 39.75万
  • 项目类别:
Development and genetics of rapid neuroendocrine stress response
快速神经内分泌应激反应的发育和遗传学
  • 批准号:
    10397544
  • 财政年份:
    2019
  • 资助金额:
    $ 39.75万
  • 项目类别:
Development and genetics of rapid neuroendocrine stress response
快速神经内分泌应激反应的发育和遗传学
  • 批准号:
    10292709
  • 财政年份:
    2019
  • 资助金额:
    $ 39.75万
  • 项目类别:
Development and genetics of rapid neuroendocrine stress response
快速神经内分泌应激反应的发育和遗传学
  • 批准号:
    10389006
  • 财政年份:
    2019
  • 资助金额:
    $ 39.75万
  • 项目类别:
Development and genetics of rapid neuroendocrine stress response
快速神经内分泌应激反应的发育和遗传学
  • 批准号:
    10601205
  • 财政年份:
    2019
  • 资助金额:
    $ 39.75万
  • 项目类别:
Building the mitochondrial genome editing repertoire
构建线粒体基因组编辑库
  • 批准号:
    10447041
  • 财政年份:
    2018
  • 资助金额:
    $ 39.75万
  • 项目类别:
Building the mitochondrial genome editing repertoire
构建线粒体基因组编辑库
  • 批准号:
    10220697
  • 财政年份:
    2018
  • 资助金额:
    $ 39.75万
  • 项目类别:
Development of tools for site-directed analysis of gene function
基因功能定点分析工具的开发
  • 批准号:
    10185650
  • 财政年份:
    2016
  • 资助金额:
    $ 39.75万
  • 项目类别:
Development of tools for site-directed analysis of gene function
基因功能定点分析工具的开发
  • 批准号:
    10575561
  • 财政年份:
    2016
  • 资助金额:
    $ 39.75万
  • 项目类别:

相似海外基金

Hippocampal neurogenesis & apoptosis in short & long-lived mammals: exploring mechanisms of divergent aging
海马神经发生
  • 批准号:
    460229-2014
  • 财政年份:
    2017
  • 资助金额:
    $ 39.75万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Hippocampal neurogenesis & apoptosis in short & long-lived mammals: exploring mechanisms of divergent aging
海马神经发生
  • 批准号:
    460229-2014
  • 财政年份:
    2016
  • 资助金额:
    $ 39.75万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Mitochondrial-mediated Nuclear Apoptosis Tracks Mass Changes of Aging Fast and Slow Twitch Muscles
线粒体介导的核细胞凋亡追踪衰老快肌和慢肌的质量变化
  • 批准号:
    337314
  • 财政年份:
    2015
  • 资助金额:
    $ 39.75万
  • 项目类别:
Osteocyte Apoptosis and Regulation of Bone Resorption with Aging
骨细胞凋亡和骨吸收随衰老的调节
  • 批准号:
    9212771
  • 财政年份:
    2015
  • 资助金额:
    $ 39.75万
  • 项目类别:
Osteocyte apoptosis and regulation of bone resorption with aging
衰老过程中骨细胞凋亡和骨吸收的调节
  • 批准号:
    9308117
  • 财政年份:
    2015
  • 资助金额:
    $ 39.75万
  • 项目类别:
Hippocampal neurogenesis & apoptosis in short & long-lived mammals: exploring mechanisms of divergent aging
海马神经发生
  • 批准号:
    460229-2014
  • 财政年份:
    2014
  • 资助金额:
    $ 39.75万
  • 项目类别:
    Postgraduate Scholarships - Doctoral
Aging, Fibroblast Senescence, and Apoptosis in Lung Fibrosis
肺纤维化中的衰老、成纤维细胞衰老和细胞凋亡
  • 批准号:
    8698307
  • 财政年份:
    2012
  • 资助金额:
    $ 39.75万
  • 项目类别:
Aging, Fibroblast Senescence, and Apoptosis in Lung Fibrosis
肺纤维化中的衰老、成纤维细胞衰老和细胞凋亡
  • 批准号:
    8971617
  • 财政年份:
    2012
  • 资助金额:
    $ 39.75万
  • 项目类别:
Aging, Fibroblast Senescence, and Apoptosis in Lung Fibrosis
肺纤维化中的衰老、成纤维细胞衰老和细胞凋亡
  • 批准号:
    8332589
  • 财政年份:
    2012
  • 资助金额:
    $ 39.75万
  • 项目类别:
Aging, Fibroblast Senescence, and Apoptosis in Lung Fibrosis
肺纤维化中的衰老、成纤维细胞衰老和细胞凋亡
  • 批准号:
    8512528
  • 财政年份:
    2012
  • 资助金额:
    $ 39.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了